Bristol-Myers Squibb Company (BMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-1992 | 12-1991 | 09-1991 | 06-1991 | 03-1991 | |
| Sales | 2,641,438 | 2,349,000 | 2,757,000 | 2,730,000 | 2,735,000 |
| Cost of Goods | 708,000 | 551,000 | 713,000 | 710,000 | 743,000 |
| Gross Profit | 2,075,000 | 2,173,000 | 2,044,000 | 2,020,000 | 1,992,000 |
| Operating Expenses | 1,324,000 | 1,207,000 | 1,260,000 | 1,325,000 | 1,288,000 |
| Operating Income | 609,438 | 591,000 | 784,000 | 695,000 | 704,000 |
| Other Income | 141,562 | 10,000 | 0 | 0 | 0 |
| Pre-tax Income | 751,000 | 601,000 | 784,000 | 695,000 | 704,000 |
| Income Tax | 203,000 | 156,000 | 221,000 | 205,000 | 211,000 |
| Net Income Continuous | 534,150 | 445,000 | 563,000 | 490,000 | 493,000 |
| Net Income Discontinuous | -232,626 | 65,000 | 0 | 0 | 0 |
| Net Income | $301,524 | $510,000 | $563,000 | $490,000 | $493,000 |
| EPS Basic Total Ops | 0.27 | 0.25 | 0.27 | 0.24 | 0.24 |
| EPS Basic Continuous Ops | 0.26 | 0.21 | 0.27 | 0.24 | 0.24 |
| EPS Basic Discontinuous Ops | -0.11 | 0.03 | N/A | N/A | N/A |
| EPS Diluted Total Ops | 0.15 | 0.25 | 0.27 | 0.24 | 0.24 |
| EPS Diluted Continuous Ops | 0.26 | 0.21 | 0.27 | 0.24 | 0.24 |
| EPS Diluted Discontinuous Ops | -0.11 | 0.03 | N/A | N/A | N/A |
| EBITDA(a) | $609,438 | $591,000 | $784,000 | $695,000 | $704,000 |